Press Releases
Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection
REC-3964 is Recursion’s first new chemical entity developed using the RecursionOS. REC-3964 represents a novel, non-antibiotic approach with a unique mechanism of action that binds and blocks catalytic activity of the toxin’s innate glucosyltransferase in order to inhibit the toxin
Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection
REC-3964 is Recursion’s first new chemical entity developed using the RecursionOS. REC-3964 represents a novel, non-antibiotic approach with a unique mechanism of action that binds and blocks catalytic activity of the toxin’s innate glucosyltransferase in order to inhibit the toxin
Incroyable Jeff ! IriusRisk présente un outil basé sur l’IA capable de générer des modèles de menaces à partir d’images
La plateforme de modélisation des menaces lance « Jeff : Assistant IA », une première mondiale en termes de création de modèles de menaces à travers le langage et les images. Cette nouvelle fonctionnalité marque l’un des tout derniers développements
Unbelievable Jeff! IriusRisk introduces an AI-powered tool which can generate threat models from images
The threat modeling platform launches ‘Jeff: AI Assistant’, a world first in terms of creating threat models through language and images. The new feature is the latest development in IriusRisk’s expansion into AI, a move which helped to deliver more
Quantexa Recognized as Category Leader in the RiskTech Quadrant® for KYC Solutions
Quantexa earned a top ranking in the RiskTech100® 2025 Report, highlighting its strength and innovation in the expanding risk technology and compliance market LONDON, Oct. 22, 2024 (GLOBE NEWSWIRE) — Quantexa, a leading provider of Decision Intelligence solutions for public
Leil Storage: Green File Storage for Africa
Leil Storage for Africa TALLINN, Estonia, Oct. 21, 2024 (GLOBE NEWSWIRE) — In alignment with Africa Human Rights Day, Leil Storage announces the expansion of its Green Storage Initiative, an endeavor set to revolutionize file storage across Africa. This initiative
Transforming Finance Through Scalable Infrastructure: Join the Digital Finance Breakfast in Sandton
JOHANNESBURG, Oct. 21, 2024 (GLOBE NEWSWIRE) — IT News Africa, in partnership with OADC, is excited to announce an exclusive Digital Finance Breakfast on 29 October 2024 at the Radisson Blu, Sandton. This highly anticipated event will focus on the
Angelini Pharma Enters Into An Exclusive Option Agreement With Cureverse to License Global Development and Commercialization Rights For A Novel and Innovative Clinical-Stage Brain Health Asset
The agreement gives Angelini Pharma an option to exclusive licensing rights to develop and commercialize CV-011, a clinical Phase 1 investigational novel compound with broad potential to treat brain health diseases Cureverse receives undisclosed upfront payments and is eligible for